These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 12478454)
1. Treatment of severe pulmonary hemorrhage with activated recombinant factor VII (rFVIIa) in very low birth weight infants. Olomu N; Kulkarni R; Manco-Johnson M J Perinatol; 2002 Dec; 22(8):672-4. PubMed ID: 12478454 [TBL] [Abstract][Full Text] [Related]
2. The use of recombinant activated factor VII in the treatment of massive pulmonary hemorrhage in a preterm infant. Cetin H; Yalaz M; Akisu M; Karapinar DY; Kavakli K; Kultursay N Blood Coagul Fibrinolysis; 2006 Apr; 17(3):213-6. PubMed ID: 16575260 [TBL] [Abstract][Full Text] [Related]
3. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Brady KM; Easley RB; Tobias JD Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833 [TBL] [Abstract][Full Text] [Related]
4. Treatment of acute pulmonary haemorrhage in extremely preterm infants with recombinant activated factor VII. Poralla C; Hertfelder HJ; Oldenburg J; Müller A; Bartmann P; Heep A Acta Paediatr; 2010 Feb; 99(2):298-300. PubMed ID: 19839953 [No Abstract] [Full Text] [Related]
5. Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study. Cosar H; Isik H; Cakır SC; Yar N; Goksen B; Tokbay H; Kertmen H; Erdoğan N; Durak I Paediatr Drugs; 2017 Feb; 19(1):53-58. PubMed ID: 27826851 [TBL] [Abstract][Full Text] [Related]
6. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [TBL] [Abstract][Full Text] [Related]
7. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation. Fischer D; Schloesser R; Buxmann H; Veldman A J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565 [TBL] [Abstract][Full Text] [Related]
8. [Alveolar hemorrhage secondary to generalized systemic lupus erithematosus treated with recombinant activated factor VII. Case report and literature review]. Carrillo-Esper R; Elizondo-Argueta S; Sánchez-Zúñiga Mde J; Carrillo-Córdova JR Gac Med Mex; 2007; 143(1):83-6. PubMed ID: 17388100 [TBL] [Abstract][Full Text] [Related]
9. Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa. Filan PM; Mills JF; Clarnette TD; Ekert H; Ekert P J Pediatr; 2005 Dec; 147(6):857-9. PubMed ID: 16356448 [TBL] [Abstract][Full Text] [Related]
10. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Heslet L; Nielsen JD; Levi M; Sengeløv H; Johansson PI Crit Care; 2006; 10(6):R177. PubMed ID: 17184515 [TBL] [Abstract][Full Text] [Related]
11. Control of bleeding associated with hemophagocytic syndrome in children: an audit of the clinical use of recombinant activated factor VII. Celkan T; Alhaj S; Civilibal M; Elicevik M Pediatr Hematol Oncol; 2007 Mar; 24(2):117-21. PubMed ID: 17454777 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review. Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055 [TBL] [Abstract][Full Text] [Related]
13. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency. Huang WY; Kruskall MS; Bauer KA; Uhl L; Shaz BH Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160 [TBL] [Abstract][Full Text] [Related]
14. Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia. Wróbel G; Dobaczewski G; Patkowski D; Sokół A; Grotthus E Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):729-30. PubMed ID: 16933258 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage]. Dabar G; Harmouche C; Jammal M Rev Mal Respir; 2011 Jan; 28(1):106-11. PubMed ID: 21277485 [TBL] [Abstract][Full Text] [Related]
17. High-frequency ventilation in the management of very-low-birth-weight infants with pulmonary hemorrhage. AlKharfy TM Am J Perinatol; 2004 Jan; 21(1):19-26. PubMed ID: 15017478 [TBL] [Abstract][Full Text] [Related]
18. Recombinant factor VIIa use following massive pulmonary hemorrhage after CPB. Courtney H Paediatr Anaesth; 2009 Mar; 19(3):272. PubMed ID: 19236650 [No Abstract] [Full Text] [Related]
19. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia]. Levi M; Friederich PW; van der Meer J Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2534-7. PubMed ID: 12532665 [TBL] [Abstract][Full Text] [Related]
20. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]